Risankizumab Biosimilar (Chong Kun Dang Pharmaceutical Corp)
利生奇珠单抗生物类似药（Chong Kun Dang Pharmaceutical Corp）
Report date: 2025/12/04 20:00:08
Base Information
Drug NameRisankizumab Biosimilar (Chong Kun Dang Pharmaceutical Corp)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesChong Kun Dang Pharmaceutical Corp
China Registration ClassN/A
Develop Information
Active CompaniesChong Kun Dang Pharmaceutical Corp
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A